Advertiser / Brand · vs · Advertiser / Brand · Direct-to-Consumer (D2C) Brand
Kenvue vs Live it Up
Structured technology and market comparison · 2026
Direct Feature Comparison
Kenvue · vs · Live it UpPublic consumer health brand owner spun out from Johnson & Johnson.
Direct-to-consumer superfood and hydration brand.
Analyze all overlapping signals and tech stacks for Kenvue and Live it Up
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Kenvue and Live it Up?
When comparing Kenvue and Live it Up, both platforms operate within the Advertiser / Brand ecosystem. Kenvue is positioned as Public consumer health brand owner spun out from Johnson & Johnson, whereas Live it Up focuses on Direct-to-consumer superfood and hydration brand. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Kenvue and Live it Up?
When evaluating Kenvue and Live it Up, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Kenvue and Live it Up compare?
Kenvue is headquartered in US (founded in 2023) with >5,000 employees. Live it Up is based in USA (founding year unrecorded) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Kenvue vs Live it Up
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Kenvue
Recent Signals
- ·Manager MagazinM&A
EU Clears Kenvue Deal; Kimberly-Clark to Divest Tampon Brands
The European Commission has conditionally approved Kimberly-Clark's $48.8 billion acquisition of Kenvue, a US consumer goods company, on October 14, 2026. To address antitrust concerns, Kimberly-Clark must divest its feminine care brands—Kotex, Lidie, Camelia, and Record—in the European Economic Area (EEA), including trademarks, intellectual property, technical know-how, key employees, and business relationships. Turkish company Dilek (or Dilek Gıda) has been approved as the buyer. The Commission's investigation focused on tampon markets in Czechia, Estonia, and Slovakia, where the merger would have reduced competition. The merger, notified to the EU on August 25, 2026, combines Kimberly-Clark's hygiene products with Kenvue's health and personal care brands such as Neutrogena and Listerine. Kenvue was spun off from Johnson & Johnson in 2023.
- Kimberly-Clark acquires Kenvue for $48.8 billion, with EU approval granted on October 14, 2026, subject to conditions.
- Kimberly-Clark must divest feminine care brands Kotex, Lidie, Camelia, and Record in the EEA.
- Turkish company Dilek (Dilek Gıda) was approved as the buyer of the divested business.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kenvue (2026-10-13)
On October 9, 2026, Kenvue Inc. entered into a Third Supplemental Indenture with Deutsche Bank Trust Company Americas to amend indentures governing seven series of senior notes due between 2028 and 2063. The execution follows consent solicitations conducted by Kimberly-Clark Corporation in connection with its offer to exchange existing Kenvue notes for up to $7.0 billion aggregate principal amount of new Kimberly-Clark notes and cash, linked to Kimberly-Clark's pending acquisition of Kenvue. The supplemental indenture strips substantially all restrictive covenants, SEC reporting obligations, consolidation/merger restrictions, and certain events of default across the notes, which will become fully operative upon settlement of the exchange offers around the transaction's closing.
- Kenvue executed a Third Supplemental Indenture on October 9, 2026, covering seven senior notes tranches maturing in 2028, 2030, 2032, 2033, 2043, 2053, and 2063.
- The amendments support Kimberly-Clark's exchange offer of up to $7,000,000,000 aggregate principal amount of existing notes into new Kimberly-Clark notes and cash.
- The operative provisions eliminate substantially all restrictive covenants, SEC reporting duties, and merger/asset transfer restrictions upon the exchange offer settlement.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for Kenvue (2026-08-06)
Kenvue reported its Q2 2026 financial results with net sales growing 3.0% year-over-year to $3.96 billion (1.6% organic growth), driven by pricing actions across international markets and strong e-commerce performance. Operating income reached $699 million and net income grew 8.6% to $456 million ($0.24 diluted EPS), supported by a lower effective tax rate of 23.7%. Operating cash flows for the first six months strengthened to $1.18 billion. Strategically, Kenvue is advancing toward the completion of its pending merger with Kimberly-Clark Corporation, expected to close in Q4 2026 following shareholder approvals and U.S. antitrust clearance. The company also initiated its 2026 Restructuring Initiative aimed at driving supply chain efficiencies and delivering $200 million in annualized pre-tax gross savings.
- Net sales for Q2 2026 reached $3.955 billion, an increase of 3.0% YoY (1.6% organic growth with 0.9% price/mix and 0.7% volume).
- Net income for the quarter increased 8.6% YoY to $456 million, with diluted earnings per share rising to $0.24 compared to $0.22 in Q2 2025.
- Pending acquisition by Kimberly-Clark received shareholder approval and HSR waiting period expiration, targeting a Q4 2026 close where Kenvue shareholders will own ~46% of the combined entity.
Live it Up
Recent Signals
No recent market signals documented for Live it Up in the current tracking window.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Kenvue and Live it Up share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks